Polar Capital Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$20M	Sell	551,383 -100,000	-15%	-$3.64M	0.1%	144
2025 Q1	$23.6M	Buy	+651,383	New	+$23.6M	0.14%	137